2nd Interim Analysis And IDH Status Of The EORTC Randomized Phase III CATNON Trial, On Adjuvant And Concurrent Temozolomide In Anaplastic Astrocytoma

Research output: Contribution to journalArticle

20 Downloads (Pure)
Original languageEnglish
JournalThe Lancet Oncology
Publication statusAccepted/In press - 2021

Cite this